Susanna Naggie, MD, was selected as a member of the 2021-2022 class of fellows for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program at Drexel University College of Medicine.
New studies are underway at Duke to test treatments that could help people with COVID-19 recover faster and avoid being hospitalized.
Dean Mary Klotman, MD, has announced that Susanna Naggie, MD, associate professor of medicine (Infectious Diseases), has been named the new Vice Dean for Clinical Research for the Duke University School of Medicine.
Laurie Snyder, MD, associate professor of medicine (Pulmonary, Allergy, and Critical Care Medicine), has agreed to serve as Medical Director of the Department of Medicine Clinical Research Unit, effective March 1.
The Infectious Diseases Society of America (IDSA) has presented its 2018 Oswald Avery Award for Early Achievement to Susanna Naggie, MD, MHS, associate professor of medicine (Infectious Diseases), for her novel research on the treatment of patients co-infected with HIV and hepatitis C virus (HCV).
School of Medicine Office for Faculty Development has announced the next class in its ALICE program, a leadership development opportunity for mid-career women faculty in the School of Medicine. Five participants in the next class are from the Department of Medicine.
The Duke School of Medicine has selected additional faculty members for the Duke Health Scholars and Duke Health Fellows Program. Among the faculty honored are six individuals from the Department of Medicine.
Susanna Naggie, MD, associate professor of medicine (Infectious Diseases), has been asked to serve on the U.S. Department of Health and Human Services (DHHS) Guidelines Panel for Antiretroviral Use in Adults and Adolescents with HIV.
Friday will be a particularly busy day in the Department of Medicine.
The Duke Human Vaccine Institute’s Vaccine and Treatment Evaluation Unit has been awarded a $5 million contract